In STAT’s first webinar, biotech reporters Adam Feuerstein and Damian Garde review last year’s highs and lows and tell you what trends, trial readouts, and M&A shake-ups they’re looking out for in 2018. They also offer a quick orientation on what to expect leading into JPM ’18.
Download slides here.